The S&P 500 and Dow Jones industrial average notched record closing highs on Monday as news of another promising coronavirus vaccine fanned hopes of eradicating COVID-19, while spiking infections and new shutdowns threatened to hobble a recovery from the pandemic recession.
All three major U.S. stock indexes advanced and with its new closing record, the blue-chip Dow is the last of the three to reclaim levels reached in February, before lockdowns sent the markets into free-fall. The small cap Russell 2000 index also hit an all-time closing high.
The TSX ended up more than 200 points, hitting its highest levels since February, but still well below its all-time peak. Energy stocks propelled a lot of the gains.
In both Canada and the U.S., value, cyclical and small cap shares tended to outperform the broader market.
Moderna Inc said its experimental COVID-19 vaccine was 94.5% effective in preventing infection based on interim late-state data. It was the second drugmaker in as my weeks, after Pfizer Inc, to announce promising trial data in the development of a vaccine to defeat the pandemic. Its shares gained 9.6% on the day.
Combined, pending further data and regulatory review, the United States could have as many as 60 million emergency doses available this year.
“More vaccine news is driving cyclicals, small caps and value, which would be primed if the economy reopens sooner than expected, returning us to some sense of normalcy,” said Robert Pavlik, senior portfolio manager at Dakota Wealth in Fairfield, Connecticut.
Travel-related stocks, which have been clobbered by restrictions to contain the pandemic’s spread, were in demand.
Shares of Air Canada, Chorus Aviation, United Airlines Holdings Inc, American Airlines Group Inc, Carnival Corp and Norwegian Cruise Line Holdings Ltd jumped between 4.5% and 9.7%.
But COVID-19 continued its U.S. rampage, with cases surging past 11 million and record infections in 40 states, prompting states to tighten social distancing mandates.
“Wall Street is looking out six to 12 months down the road,” Pavlik added. “There is a question about ... what kind of damage will be inflicted on the economy between now and then.”
The S&P/TSX Composite Index closed up 208.68 points, or 1.25%, at 16,884.32, as energy stocks rallied 5.22%. Financials, rising by 2.45%, and real estate, climbing 2.05%, also put in a strong performance.
Cineplex enjoyed a particularly strong session, rising 15.13% on the encouraging vaccine news and as BMO upgraded its rating on the stock.
The Dow Jones Industrial Average rose 470.63 points, or 1.6%, to 29,950.44; the S&P 500 gained 41.76 points, or 1.16%, at 3,626.91; and the Nasdaq Composite added 94.84 points, or 0.8%, at 11,924.13.
Of the 11 major sectors of the S&P 500, all but healthcare ended the session in the black, with energy stocks enjoying the largest percentage gain.
Earnings from high-profile retailers are expected this week, with Walmart Inc and Home Depot Inc expected to report on Tuesday and Lowe’s Companies Inc and Target Corp on Wednesday.
This, together with the Commerce Department’s October retail sales data, expected on Tuesday, should provide evidence of how consumers are weathering a languid economic recovery as stimulus runs dry.
Advancing issues outnumbered declining ones on the NYSE by a 4.66-to-1 ratio. On Nasdaq, a 2.55-to-1 ratio favored advancers.
The S&P 500 posted 40 new 52-week highs and no new lows. The Nasdaq Composite recorded 162 new highs and 15 new lows.
Volume on U.S. exchanges was 10.90 billion shares, compared with the 10.21 billion average for the full session over the last 20 trading days.
West Texas Intermediate crude for December was up $1.21, or 3%, at $41.34, also bolstered by the vaccine news. Gold was nearly unchanged for the day.
Read more: Stocks that saw action on Monday - and why
Reuters, with files from Darcy Keith of The Globe and Mail
Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.